跳到主要内容
搜索

Associate Principal Scientist, ADC Portfolio, Heme

地点 盖瑟斯堡, 马里兰州, 美国 职位 ID R-105673 发布日期 04/18/2021

We are seeking a highly motivated Associate Principal Scientist with a proven track record of scientific excellence and project leadership in hematological oncology research to join our antibody-drug conjugates (ADCs) portfolio team within the Early Oncology Discovery group in Gaithersburg, MD USA.  As an Associate Principal Scientist you will lead a team focused on bringing new ADC projects into the portfolio and advancing them through all stages of pre-clinical development. You will bring your theoretical and practical expertise to lead pipeline projects, establishing program priorities and working with a cross-functional team to deliver pre-clinical datasets to support pipeline progression. You will represent the team in front of governance committees and will present program updates at other internal forums.  You will also make intellectual contributions to programs across the ADC Portfolio and be an engaged people manager and mentor.

Main Duties and Responsibilities

  • You will be expected to serve as Oncology biology lead for one or more pipeline programs, working collaboratively with cross-functional teams to ensure the timely generation and dissemination of critical program data to enable milestone progression decisions. 
  • You will help set program strategy, and will be responsible for the delivery of key pre-clinical data that support a strong biological rationale for program progression.
  • You will be expected to work independently and collaboratively, and effectively plan and organize work activities and prioritize task completion for yourself and direct reports
  • You will manage and mentor a team of direct reports
  • As a highly organized, self-motivated individual with a strong background in cancer biology, you will stay up to date with relevant technical and intellectual scientific expertise in tumor biology and cancer modelling, particularly as it relates to antibody drug conjugates, and have a genuine passion for this field of research. 

Essential Requirements

  • Ph.D. with 5-10 years of research experience or Master’s degree with 8+ years within the pharmaceutical industry and clear demonstration of solving challenging problems in drug discovery
  • Demonstrated ability to lead cross functional project teams.
  • Demonstrated management and leadership skills and a passion for mentorship
  • Strong knowledge of hematologic cancers, in-vitro and in-vivo pre-clinical models of hematologic cancer, cell biology, molecular biology, and/or biochemistry in the context of cancer biology, with a strong desire for continued learning.
  • Works independently to design and conduct key experiments to support program progression.
  • Excellent verbal and written communication, presentation, and interpersonal skills and evidence of delivery in a team-oriented, collaborative environment.
  • A proven track record of productivity, as demonstrated by scientific publications in high quality peer-reviewed journals.
  • Ensures own work, and work of peers, is compliant with Good Laboratory Practice, Safety, Health, and Environment standards and all other relevant internal AstraZeneca standards and external regulations.
  • Prior experience in the biopharmaceutical industry preferable but not required.


AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorisation and employment eligibility verification requirements.

Glassdoor logo Rated four stars on Glassdoor

优秀的文化,出色的工作任务,充满支持的管理模式。 公司内部的轮换机会。 他们重视包容性和多样性。